Viromed Medical AG | WebDisclosure

PRESS RELEASE

published on 07/10/2024 at 07:30, 1 year 11 months ago

Viromed Medical AG seeks special approval for cold plasma device for the prevention of ventilator-associated pneumonia (VAP)
Viromed Medical AG seeks special approval for cold plasma device to prevent ventilator-associated pneumonia (VAP). Study aims to revolutionize VAP treatment & reduce mortality

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Device VAP Prevention Special Approval
BRIEF

published on 07/05/2024 at 17:35, 1 year 11 months ago

Viromed Medical AG Announces Termination of Cooperation with terraplasma medical GmbH

Termination Market Expansion Coopération Viromed Medical AG Cold Plasma Devices
BRIEF

published on 07/05/2024 at 17:35, 1 year 11 months ago

Viromed Medical AG annonce la fin de sa coopération avec terraplasma Medical GmbH

Coopération L'expansion Du Marché Viromed Medical SA Résiliation Appareils À Plasma Froid
PRESS RELEASE

published on 07/05/2024 at 17:30, 1 year 11 months ago

EQS-Adhoc: Viromed Medical AG: Viromed Medical GmbH and terraplasma medical GmbH terminate their cooperation with immediate effect
Viromed Medical AG terminates cooperation with terraplasma medical GmbH, allowing for expansion of sales potential with own cold plasma devices worldwide

Viromed Medical AG Cold Plasma Devices Terraplasma Medical GmbH Cooperation Termination Sales Potential Expansion
BRIEF

published on 04/22/2024 at 16:35, 2 years 2 months ago

Viromed Medical AG Secures Exclusive Agreement with CORIUS Group for Plasma Care® Deployment

Healthcare Partnership Viromed Medical AG CORIUS Group Plasma Care
BRIEF

published on 04/22/2024 at 16:35, 2 years 2 months ago

Viromed Medical AG conclut un accord exclusif avec le groupe CORIUS pour le déploiement de Plasma Care®

Partenariat Soins De Santé Viromed Medical SA Groupe CORIUS Soins Du Plasma
PRESS RELEASE

published on 04/22/2024 at 16:30, 2 years 2 months ago

Viromed Medical AG reaches important milestone – agreement with CORIUS Group for exclusive use of Plasma Care® by Viromed with significant growth potential
Viromed Medical AG reaches agreement with CORIUS Group for exclusive use of Plasma Care® with significant growth potential, establishing it as benchmark in Germany

Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care® Clinical Alliance
BRIEF

published on 04/22/2024 at 13:10, 2 years 2 months ago

Viromed Medical AG Secures Exclusive Rights for Cold Plasma Therapy with CORIUS Group

Medical Technology Earnings Growth Viromed Medical AG CORIUS Group Cold Plasma Therapy
BRIEF

published on 04/22/2024 at 13:10, 2 years 2 months ago

Viromed Medical AG obtient les droits exclusifs pour la thérapie par plasma froid avec le groupe CORIUS

Technologie Médicale Croissance Des Bénéfices Viromed Medical SA Groupe CORIUS Thérapie Au Plasma Froid
PRESS RELEASE

published on 04/22/2024 at 13:05, 2 years 2 months ago

EQS-Adhoc: Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected
Viromed Medical AG partners with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care®, expecting additional earnings contribution of EUR 0.28 to EUR 0.34 per share from 2025 onwards

Earnings Contribution Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care®

Published on 06/27/2026 at 01:40, 9 hours 46 minutes ago

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 11 hours 26 minutes ago

Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 12 hours 26 minutes ago

Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 12 hours 36 minutes ago

Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/26/2026 at 22:15, 13 hours 11 minutes ago

Revive Therapeutics Announces Proposed Private Placement

View all ACCESSWIRE

Published on 06/27/2026 at 00:05, 11 hours 20 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 11 hours 21 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 11 hours 50 minutes ago

Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 11 hours 50 minutes ago

EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Published on 06/26/2026 at 23:27, 11 hours 58 minutes ago

EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE

View all EQS

Published on 06/26/2026 at 17:45, 17 hours 41 minutes ago

Combined General Meeting, June 25, 2026
Published on 06/26/2026 at 17:45, 17 hours 41 minutes ago

Assemblée générale mixte du 25 juin 2026
Published on 06/26/2026 at 17:45, 17 hours 41 minutes ago

Descriptif du programme de rachat d'actions
Published on 06/26/2026 at 14:44, 20 hours 41 minutes ago

Safran information
Published on 06/26/2026 at 14:44, 20 hours 41 minutes ago

Information Safran

View all LES ECHOS COMFI WIRE

News